Pliant Therapeutics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -622 | -513 | ||
EBITDA | -48,440 | -56,354 | -54,364 | -45,997 |
EBIT | -48,898 | -56,886 | -54,986 | -46,510 |
Net Income | -49,732 | -57,763 | -55,854 | -46,955 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -47,871 | -33,169 | -46,548 | -31,763 |
Cash | 71,188 | 79,616 | 80,386 | 114,297 |
Basic Shares | 60,538 | 60,730 | 60,382 | 60,180 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $1,580 | $9,685 | $7,572 |
Gross Profit | 1,580 | 6,004 | 7,572 | |
EBITDA | -228,365 | -158,228 | -118,849 | -18,451 |
EBIT | -160,069 | -122,530 | -19,986 | |
Net Income | -210,304 | -161,336 | -121,498 | -17,907 |
Net Change In Cash | 0 | 1,580 | 9,685 | 7,572 |
Cost of Revenue | -17,981 | 783 | ||
Free Cash Flow | -159,351 | -117,282 | -96,391 | -77,396 |
Cash | 71,188 | 63,234 | 33,685 | 51,665 |
Basic Shares | 60,538 | 58,719 | 42,015 | 35,846 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.82 |
2024-09-30 | -$0.95 |
2024-06-30 | -$0.92 |
2024-03-31 | -$0.78 |
